The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6α-hydroxypaclitaxel, a major metabolite of paclitaxel

M. H. Kang, W. D. Figg*, Y. Ando, M. V. Blagosklonny, D. Liewehr, T. Fojo, S. E. Bates

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6α-hydroxypaclitaxel, a major metabolite of paclitaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences